Over 400 institutions in 34 countries are now participating in The Company of Biologists’ Read & Publish Open Access initiative. Agreements have been signed with library consortia in Australia, Germany, Ireland, Israel, Spain, the UK, and the USA. A landmark agreement with EIFL (Electronic Information for Libraries) enables researchers in 30 developing and transition economy countries to publish Open Access articles in the organization’s hybrid journals without paying an article processing charge (APC).
The success of The Company’s Read & Publish initiative has led to a significant increase in the proportion of Open Access (OA) research content in its hybrid subscription journals, which were the first from any publisher to be awarded Transformative Journal status by Plan S.
In 2021, OA research content increased by 10% in Development, 12% in Journal of Cell Science, and 15% in Journal of Experimental Biology. This meant that all journals exceeded the Transformative Journal target for OA growth of 5%. From 2022, institutions can also choose to include the publisher’s fully OA journals – Disease Models & Mechanisms and Biology Open – in their Read & Publish agreements.
Click here to read the original press release.
